| __timestamp | Vertex Pharmaceuticals Incorporated | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 580415000 | 4320000 |
| Thursday, January 1, 2015 | 1032336000 | 2538000 |
| Friday, January 1, 2016 | 1702177000 | 3337000 |
| Sunday, January 1, 2017 | 2488652000 | 4003000 |
| Monday, January 1, 2018 | 3047597000 | 8386000 |
| Tuesday, January 1, 2019 | 4162821000 | 4461000 |
| Wednesday, January 1, 2020 | 6205683000 | 1050000 |
| Friday, January 1, 2021 | 7574400000 | 2963000 |
| Saturday, January 1, 2022 | 8930700000 | 1772000 |
| Sunday, January 1, 2023 | 9869200000 | 314000 |
| Monday, January 1, 2024 | 11020100000 |
Cracking the code
In the dynamic world of biopharmaceuticals, revenue growth is a key indicator of a company's success and innovation. Over the past decade, Vertex Pharmaceuticals Incorporated has demonstrated a remarkable upward trajectory, with revenues soaring from approximately $580 million in 2014 to nearly $9.9 billion in 2023. This represents an impressive growth rate of over 1,600%, underscoring Vertex's strong market position and successful product pipeline.
In contrast, Viridian Therapeutics, Inc. has experienced a more volatile revenue pattern, peaking at around $8.4 million in 2018 before declining to $314,000 in 2023. This fluctuation highlights the challenges smaller biotech firms face in achieving consistent growth.
The data reveals a stark contrast between the two companies, with Vertex's robust growth reflecting its strategic advancements, while Viridian's journey underscores the hurdles in the competitive biotech landscape.
Annual Revenue Comparison: Novo Nordisk A/S vs Viridian Therapeutics, Inc.
Merck & Co., Inc. or Vertex Pharmaceuticals Incorporated: Who Leads in Yearly Revenue?
Revenue Insights: Gilead Sciences, Inc. and Viridian Therapeutics, Inc. Performance Compared
Vertex Pharmaceuticals Incorporated vs Genmab A/S: Examining Key Revenue Metrics
Annual Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Bio-Techne Corporation
Vertex Pharmaceuticals Incorporated vs Amneal Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Vertex Pharmaceuticals Incorporated vs HUTCHMED (China) Limited: Examining Key Revenue Metrics
Comparing Revenue Performance: Vertex Pharmaceuticals Incorporated or ImmunityBio, Inc.?
Vertex Pharmaceuticals Incorporated or Supernus Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Comparing Revenue Performance: Vertex Pharmaceuticals Incorporated or Travere Therapeutics, Inc.?
Catalent, Inc. vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
Revenue Showdown: Dynavax Technologies Corporation vs Viridian Therapeutics, Inc.